Tilray Brands, Inc. is an American pharmaceutical, cannabis-lifestyle and consumer packaged goods company, incorporated in the United States, headquartered in New York City. Tilray also has operations in Canada, Australia, New Zealand, and Latin America, with growing facilities in Germany and Portugal.
trading_symbol | registrant_name | time | price | change | percentage_change |
---|---|---|---|---|---|
TLRY | Tilray Brands, Inc. | 2025-10-16 22:20:04 | 1.54 | 0 | 0 |
trading_symbol | central_index_key | registrant_name | isin_number | lei_number | ein_number | exchange | sic_code | sic_description | fiscal_year_end | state_of_incorporation | address_street | address_city | address_state | address_zip_code | address_country | address_country_code | phone_number | mailing_address | business_address | former_name | industry | founding_date | chief_executive_officer | number_of_employees | website | market_cap | shares_issued | shares_outstanding | description | update_time |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
TLRY | 0001731348 | Tilray Brands, Inc. | US88688T1007 | — | 824310622 | Nasdaq | 2833 | Medicinal Chemicals & Botanical Products | 0531 | — | 655 MADISON AVENUE | NEW YORK | NY | 10065 | UNITED STATES | US | 519.322.8800 | 655 MADISON AVENUE, NEW YORK, NY, 10065 | 655 MADISON AVENUE, NEW YORK, NY, 10065 | Tilray, Inc. | — | 2013 | Irwin D. Simon | 1,600 | http://tilray.com | 1,300,000,000 | 1,118,291,159 | 1,122,863,166 | Tilray Brands, Inc. is an American pharmaceutical, cannabis-lifestyle and consumer packaged goods company, incorporated in the United States, headquartered in New York City. Tilray also has operations in Canada, Australia, New Zealand, and Latin America, with growing facilities in Germany and Portugal. | 2025-10-10 21:01:29 |
Fiscal Year | Market Cap | Change In Market Cap | Percentage Change In Market Cap | Shares Outstanding | Change In Shares Outstanding | Percentage Change In Shares Outstanding |
---|---|---|---|---|---|---|
2025 | 1,200,000,000 | -100,000,000 | -7.6923 | 1,100,530,099 | 257,568,342 | 30.5552 |
2024 | 1,300,000,000 | -1,100,000,000 | -45.8333 | 842,961,757 | 139,704,533 | 19.8654 |
2023 | 2,400,000,000 | 2,395,300,000 | 50,963.8298 | 703,257,224 | 166,866,458 | 31.1091 |
Executive Name | Executive Position | Fiscal Year | Salary | Bonus | Stock Awards | Incentive Plan Compensation | Other Compensation | Total Compensation |
---|---|---|---|---|---|---|---|---|
Roger Savell | Chief Administrative Officer | 2025 | 543,400 | 295,000 | 918,750 | 0 | 327,767 | 1,789,926 |
Carl Merton | Chief Financial Officer | 2025 | 395,875 | 546,500 | 669,563 | 0 | 16,862 | 1,628,800 |
Irwin Simon | Chief Executive Officer, President, Chairman Of The Board | 2025 | 1,988,000 | 3,369,950 | 4,729,400 | 0 | 208,262 | 10,295,612 |
Denise Faltischek | Chief Strategy Officer | 2025 | 621,000 | 645,000 | 1,050,000 | 0 | 39,111 | 2,355,111 |
Mitchell Gendel | Corporate Secretary, General Counsel | 2025 | 579,600 | 591,000 | 980,000 | 0 | 32,359 | 2,182,959 |
Fiscal Year | Employee Count |
---|---|
2025 | 2,842 |
2024 | 2,650 |
2023 | 1,600 |
Fiscal Year | 2025 | 2024 | 2023 |
---|---|---|---|
Revenue | 821,309,000 | 788,942,000 | 627,124,000 |
Cost Of Revenue | 580,739,000 | 565,591,000 | 480,164,000 |
Gross Profit | 240,570,000 | 223,351,000 | 146,960,000 |
Research And Development Expenses | 284,000 | 635,000 | 682,000 |
General And Administrative Expenses | 167,324,000 | 167,358,000 | 165,159,000 |
Operating Expenses | 2,523,275,000 | 398,096,000 | 1,516,645,000 |
Operating Income | -2,282,705,000 | -174,745,000 | -1,369,685,000 |
Net Income | -2,186,738,000 | -244,981,000 | -1,452,656,000 |
Earnings Per Share Basic | -2.46 | -0.33 | -2.35 |
Earnings Per Share Diluted | -2.46 | -0.33 | -2.35 |
Weighted Average Shares Outstanding Basic | 890,326,017 | 742,649,477 | 617,982,589 |
Weighted Average Shares Outstanding Diluted | 890,326,017 | 742,649,477 | 617,982,589 |
Fiscal Year | 2025 | 2024 | 2023 |
---|---|---|---|
Cash And Cash Equivalents | 221,666,000 | 228,340,000 | 206,632,000 |
Marketable Securities Current | 34,697,000 | 32,182,000 | 241,897,000 |
Accounts Receivable | 121,489,000 | 101,695,000 | 86,227,000 |
Inventories | 270,882,000 | 252,087,000 | 200,551,000 |
Non Trade Receivables | 0 | 0 | 0 |
Other Assets Current | — | — | — |
Total Assets Current | 688,626,000 | 677,710,000 | 773,029,000 |
Marketable Securities Non Current | 10,132,000 | 7,859,000 | 7,795,000 |
Property Plant And Equipment | 568,433,000 | 558,247,000 | 429,667,000 |
Other Assets Non Current | 11,084,000 | 5,395,000 | 222,000 |
Total Assets Non Current | 0 | 32,000,000 | 74,681,000 |
Total Assets | 2,074,327,000 | 4,221,665,000 | 4,307,259,000 |
Accounts Payable | 107,348,000 | 105,392,000 | 70,819,000 |
Deferred Revenue | — | — | — |
Short Term Debt | 7,181,000 | 18,033,000 | 23,381,000 |
Other Liabilities Current | 103,260,000 | 92,424,000 | 82,240,000 |
Total Liabilities Current | 280,303,000 | 299,170,000 | 432,979,000 |
Long Term Debt | 86,428,000 | 129,583,000 | 221,044,000 |
Other Liabilities Non Current | 855,000 | 90,000 | 215,000 |
Total Liabilities Non Current | 0 | 0 | 0 |
Total Liabilities | 584,752,000 | 778,487,000 | 977,316,000 |
Common Stock | 106,000 | 83,000 | 66,000 |
Retained Earnings | -4,847,226,000 | -2,660,488,000 | -2,415,507,000 |
Accumulated Other Comprehensive Income | -43,063,000 | -43,499,000 | -46,610,000 |
Total Shareholders Equity | 1,511,474,000 | 3,442,906,000 | 3,315,692,000 |
Fiscal Year | 2025 | 2024 | 2023 |
---|---|---|---|
Depreciation And Amortization | 133,490,000 | 126,913,000 | 130,149,000 |
Share Based Compensation Expense | 24,289,000 | 31,769,000 | 39,595,000 |
Other Non Cash Income Expense | 2,203,000 | -13,626,000 | -11,406,000 |
Change In Accounts Receivable | 17,801,000 | 6,575,000 | -4,168,000 |
Change In Inventories | 13,561,000 | 15,578,000 | 12,934,000 |
Change In Non Trade Receivables | — | — | — |
Change In Other Assets | — | — | — |
Change In Accounts Payable | -22,938,000 | 212,000 | 20,044,000 |
Change In Other Liabilities | — | — | — |
Cash From Operating Activities | -94,599,000 | -30,905,000 | 7,906,000 |
Purchases Of Marketable Securities | — | — | 241,897,000 |
Sales Of Marketable Securities | — | — | — |
Acquisition Of Property Plant And Equipment | 32,917,000 | 29,249,000 | 20,800,000 |
Acquisition Of Business | 18,110,000 | 60,626,000 | 26,718,000 |
Other Investing Activities | — | — | — |
Cash From Investing Activities | -46,718,000 | 128,349,000 | -285,111,000 |
Tax Withholding For Share Based Compensation | 0 | 0 | 1,189,000 |
Payments Of Dividends | — | — | — |
Issuance Of Common Stock | 161,188,000 | 8,619,000 | 129,593,000 |
Repurchase Of Common Stock | — | — | — |
Issuance Of Long Term Debt | — | — | 1,288,000 |
Repayment Of Long Term Debt | 181,000 | 100,000,000 | 194,000 |
Other Financing Activities | — | — | — |
Cash From Financing Activities | 133,506,000 | -75,187,000 | 70,158,000 |
Change In Cash | -6,674,000 | 21,708,000 | -209,277,000 |
Cash At End Of Period | 221,666,000 | 228,340,000 | 206,632,000 |
Income Taxes Paid | — | — | — |
Interest Paid | 41,331,000 | 49,264,000 | 46,612,000 |
Fiscal Year | 2025 | 2024 | 2023 |
---|---|---|---|
Earnings Per Share | -2.46 | -0.33 | -2.35 |
Price To Earnings Ratio | -0.173 | -5.4545 | -0.7106 |
Earnings Growth Rate | 645.4545 | -85.9574 | 161.1111 |
Price Earnings To Growth Ratio | -0.0003 | 0.0635 | -0.0044 |
Book Value Per Share | 1.6731 | 4.6363 | 5.3884 |
Price To Book Ratio | 0.2544 | 0.3882 | 0.3099 |
Ebitda | -2,011,917,000 | -68,804,000 | -1,275,895,000 |
Enterprise Value | 250,954,785.4369 | 1,256,045,058.6 | 1,069,823,923.63 |
Dividend Yield | — | — | — |
Dividend Payout Ratio | — | — | — |
Debt To Equity Ratio | 0.0619 | 0.0429 | 0.0737 |
Capital Expenditures | 143,676,000 | 255,493,000 | -27,683,000 |
Free Cash Flow | -238,275,000 | -286,398,000 | 35,589,000 |
Return On Equity | -1.4468 | -0.0712 | -0.4381 |
One Year Beta | 1.4308 | 1.123 | 1.7662 |
Three Year Beta | 1.5318 | 1.6696 | 1.7945 |
Five Year Beta | 1.6458 | 1.5541 | 1.5447 |
Insider Name | Relationship To Issuer | Transaction Date | Amount Of Securities | Acquired Or Disposed | Securities Owned Following Transaction |
---|---|---|---|---|---|
FALTISCHEK DENISE M | Chief Strategy Officer | 2025-07-31 | 93,928 | A | 874,564 |
FALTISCHEK DENISE M | Chief Strategy Officer | 2025-07-31 | 49,782 | D | 824,782 |
FALTISCHEK DENISE M | Chief Strategy Officer | 2025-07-31 | 46,964 | D | 0 |
Gendel Mitchell | Global General Counsel | 2025-07-31 | 93,928 | A | 742,069 |
Gendel Mitchell | Global General Counsel | 2025-07-31 | 49,782 | D | 692,287 |
Name Of Reporting Person | Report Date | State | Transaction Type | Transaction Date | Owner Type | Amount |
---|---|---|---|---|---|---|
Brian Mast | 2022-10-05 | FL18 | Exchange | 2021-05-03 | — | $1,001 - $15,000 |
Brian Mast | 2022-08-12 | FL18 | Sale | 2021-02-10 | — | $50,001 - $100,000 |
Brian Mast | 2022-08-12 | FL18 | Sale (Partial) | 2021-02-09 | — | $15,001 - $50,000 |
Brian Mast | 2022-08-12 | FL18 | Sale (Partial) | 2021-02-09 | — | $15,001 - $50,000 |
Brian Mast | 2022-05-09 | FL18 | Sale | 2022-04-18 | — | $1,001 - $15,000 |
Investor Name | Period Of Report | Market Value | Amount Of Securities | Price Per Security |
---|---|---|---|---|
PFS Partners, LLC | 2025-09-30 | 35,140 | 20,312 | 1.73 |
Regent Peak Wealth Advisors LLC | 2025-09-30 | 24,222 | 14,001 | 1.73 |
CWM, LLC | 2025-09-30 | 125,000 | 72,091 | 1.7339 |
JEPPSON WEALTH MANAGEMENT, LLC | 2025-09-30 | 34,600 | 20,000 | 1.73 |
World Investment Advisors | 2025-09-30 | 37,633 | 21,753 | 1.73 |
Registrant Name | Period Of Report | Fund Name | Fund Symbol | Amount Of Units | Value In Usd | Percentage Value Compared To Assets |
---|---|---|---|---|---|---|
INVESCO EXCHANGE-TRADED FUND TRUST | 2025-07-31 | Invesco RAFI US 1500 Small-Mid ETF | PRFZ | 976,343 | 567,157.65 | 0.0239 |
Invesco Exchange-Traded Fund Trust II | 2025-07-31 | Invesco RAFI Developed Markets ex-U.S. Small-Mid ETF | PDN | 234,669 | 136,319.22 | 0.0383 |
iSHARES TRUST | 2025-07-31 | iShares U.S. Small-Cap Equity Factor ETF | SMLF | 434,703 | 252,518.97 | 0.0131 |
Dimensional ETF Trust | 2025-07-31 | Dimensional International Core Equity Market ETF | DFAI | 21,635 | 12,567.77 | 0.0001 |
Dimensional ETF Trust | 2025-07-31 | Dimensional International Small Cap ETF | DFIS | 215,692 | 123,248.11 | 0.0037 |